These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6204352)

  • 1. Reduced haloperidol: effects on striatal dopamine metabolism and conversion to haloperidol in the rat.
    Korpi ER; Wyatt RJ
    Psychopharmacology (Berl); 1984; 83(1):34-7. PubMed ID: 6204352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of extracellular DOPAC, HVA and 5-HIAA in rat striatum in vivo by differential pulse voltammetry: effect of phencyclidine, haloperidol and their coadministration.
    Crespi F; Keane PE
    Pharmacol Res Commun; 1987 Sep; 19(9):639-49. PubMed ID: 2448834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
    Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
    Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
    See RE
    Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain.
    Kashihara K; Sato M; Fujiwara Y; Harada T; Ogawa T; Otsuki S
    Biol Psychiatry; 1986 Jun; 21(7):650-6. PubMed ID: 3011131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-related changes in serum perphenazine, striatal 3H-spiperone binding and regional brain acid metabolites of dopamine and 5-hydroxy-tryptamine after a single dose of perphenazine.
    Mjörndal T; Persson SA
    Fundam Clin Pharmacol; 1990; 4(2):213-22. PubMed ID: 1693589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
    Massotti M
    Pharmacol Res Commun; 1977 Apr; 9(4):381-9. PubMed ID: 559310
    [No Abstract]   [Full Text] [Related]  

  • 9. Haloperidol inhibits the disappearance of acidic dopamine metabolites from rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    J Pharm Pharmacol; 1978 Sep; 30(9):583-5. PubMed ID: 29101
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats.
    See RE; Murray CE
    Neurosci Lett; 1992 Aug; 142(1):100-4. PubMed ID: 1383895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo.
    Kaneko M; Sato K; Horikoshi R; Yaginuma M; Yaginuma N; Shiragata M; Kumashiro H
    Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):53-7. PubMed ID: 1378633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic verapamil modifies striatal and frontal cortex dopamine levels.
    Sitges M; Guarneros A
    Eur Neuropsychopharmacol; 1998 May; 8(2):105-11. PubMed ID: 9619688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover.
    Lerner P; Nosé P; Gordon EK; Lovenberg W
    Science; 1977 Jul; 197(4299):181-3. PubMed ID: 17917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
    Toide K; Unemi N; Segawa T
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):111-24. PubMed ID: 3925907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyclo (Leu-Gly) on neurochemical indices of striatal dopaminergic supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Fage D; Scatton B
    Life Sci; 1984 Jan; 34(4):393-9. PubMed ID: 6694528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites.
    Wong DT; Threlkeld PG; Bymaster FP
    Arzneimittelforschung; 1993 Apr; 43(4):409-12. PubMed ID: 7684223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
    Toru M; Mataga N; Takashima M; Nishikawa T
    Psychopharmacology (Berl); 1981; 74(4):316-20. PubMed ID: 6794073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of neuropeptide Y on striatal catecholamines.
    Beal MF; Frank RC; Ellison DW; Martin JB
    Neurosci Lett; 1986 Oct; 71(1):118-23. PubMed ID: 2431356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the relation between haloperidol-induced alterations in DA release and DA metabolism in rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    Life Sci; 1978 Aug; 23(6):611-5. PubMed ID: 692284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.